Abstract

Trypanosoma cruzi, the etiological agent of Chagas' disease, presents nutritional requirements for several metabolites. It requires heme for the biosynthesis of several heme-proteins involved in essential metabolic pathways like mitochondrial cytochromes and respiratory complexes, as well as enzymes involved in the biosynthesis of sterols and unsaturated fatty acids. However, this parasite lacks a complete route for its synthesis. In view of these facts, T. cruzi has to incorporate heme from the environment during its life cycle. In other words, their hosts must supply the heme for heme-protein synthesis. Although the acquisition of heme is a fundamental issue for the parasite’s replication and survival, how this cofactor is imported and distributed is poorly understood. In this work, we used different fluorescent heme analogs to explore heme uptake along the different life-cycle stages of T. cruzi, showing that this parasite imports it during its replicative stages: the epimastigote in the insect vector and the intracellular amastigote in the mammalian host. Also, we identified and characterized a T. cruzi protein (TcHTE) with 55% of sequence similarity to LHR1 (protein involved in L. amazonensis heme transport), which is located in the flagellar pocket, where the transport of nutrients proceeds in trypanosomatids. We postulate TcHTE as a protein involved in improving the efficiency of the heme uptake or trafficking in T. cruzi.

Highlights

  • Trypanosoma cruzi is the etiological agent of Chagas' disease or American trypanosomiasis

  • In this work we used the derivatives of protoporphyrin IX ZnPP (Zn(II) protoporphyrin IX) and GaPP (Ga(III) protoporphyrin IX) and the derivatives of mesoporphyrin IX ZnMP (Zn(II) mesoporphyrin IX) and Sn(IV) mesoporphyrin IX (SnMP) (Sn(IV)

  • The confocal images revealed that ZnPP and ZnMP were clearly imported and maintained by the parasite while samples treated with GaPP and SnMP did not show the expected signal

Read more

Summary

Introduction

Trypanosoma cruzi is the etiological agent of Chagas' disease or American trypanosomiasis. It is estimated that about 6 to 7 million people are infected worldwide, mostly in Latin America and southern states of USA, where Chagas’ disease is considered endemic. It is becoming relevant in non-endemic regions due to migrations and the absence of control in blood banks and organ transplantation (http://www.who.int/mediacentre/factsheets/fs340/en/) [1,2]. T. cruzi has a complex life cycle alternating between two hosts and displaying at least four developmental stages. It is present as intracellular forms, mainly amastigotes (replicative stage) or transiently as intracellular epimastigotes, and as bloodstream trypomastigotes (non replicative, infective stage). During the different life-cycle stages, the parasite faces different environments and has to adapt its metabolism to the nutritional availability through the different hosts [3,4]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call